SCHEMBL499569

SCHEMBL499569

OCCOC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220922 1.00 TSHR (0.37)
Hydroxyl Radical SCHEMBL28330571 0.97
SCHEMBL16683329 0.89 NPC1 (0.31)
SCHEMBL330971 0.88
SCHEMBL321202 0.88
SCHEMBL25150041 0.87 PIK3CA (0.32)
SCHEMBL10959574 0.87 ALDH1A1 (0.35)
SCHEMBL7190129 0.87 TSHR (0.35)
SCHEMBL8202249 0.87 ALDH1A1 (0.35)
SCHEMBL16670912 0.87 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025056984-A1 A NOVEL PROCESS FOR THE PREPARATION OF BEXAGLIFLOZIN A SGLT2 INHIBITOR AND ITS INTERMEDIATES THEREOF VIJAYASRI ORGANICS PRIVATE LIMITED (IN) 2025-03-20 WO claimed
CN-118851889-A Preparation method of Liujing intermediate 浙江永太科技股份有限公司 2024-10-29 CN claimed
CN-118619823-A Preparation method of 4-bromo-1-chloro-2- (4- (2-cyclopropyloxy ethoxy) benzyl) benzene 杭州科巢生物科技有限公司 2024-09-10 CN claimed
CN-118619824-A Preparation method of 4-iodo-1-chloro-2- (4- (2-cyclopropyloxy ethoxy) benzyl) benzene 杭州科巢生物科技有限公司 2024-09-10 CN claimed
EP-2380878-B1 CYCLIC COMPOUND HAVING HETERO ATOM DAIICHI SANKYO CO LTD (JP) 2013-08-14 EP claimed
US-20110269746-A1 CYCLIC COMPOUND HAVING HETERO ATOM DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-11-03 US claimed
EP-2380878-A1 CYCLIC COMPOUND HAVING HETERO ATOM Daiichi Sankyo Company, Limited (JP) 2011-10-26 EP claimed
US-20260124205-A1 MODULATORS OF BETA CATENIN AND USES THEREOF DEWPOINT THERAPEUTICS INC (US) 2026-05-07 US disclosed
EP-4262788-B1 UREA OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME LLC (US) 2026-01-21 EP disclosed
US-12528781-B2 Heterocyclic GLP-1 agonists GASHERBRUM BIO, INC. (US) 2026-01-20 US disclosed
CN-121318680-A Bexagliflozin middle Process for the preparation of intermediates 浙江永太科技股份有限公司 2026-01-13 CN disclosed
EP-4192831-B1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO INC (US) 2025-10-22 EP disclosed
EP-4549438-A1 FIVE-MEMBERED AND SIX-MEMBERED NITROGEN-CONTAINING COMPOUND, AND INTERMEDIATE, PREPARATION METHOD AND USE THEREOF Hangzhou Synrx Therapeutics Biomedical Technology Co., Ltd. (CN) 2025-05-07 EP disclosed
EP-0889034-B1 AMINOPYRIDINE DERIVATIVES BANYU PHARMA CO LTD (JP) 2003-09-17 EP disclosed
US-6011039-A USEFUL AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS; TREATING HYPERPHAGIA, OBESITY OR DIABETES BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-01-04 US disclosed
EP-0889034-A1 AMINOPYRIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-01-07 EP disclosed
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed
US-5145675-A Polymerizing suspended monomers in presence of porogen to form rigid crosslinked beads with internal pore network, extracting porogen, introducing active substance ADVANCED POLYMER SYSTEMS, INC. (US) 1992-09-08 US disclosed
US-4010141-A Anti-fouling composition for use in water comprising a polymer and an organo tin compound KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JA) 1977-03-01 US disclosed